Intersect Capital’s Abiomed Inc ABMD Stock Holding History

Intersect Capital’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-748	Closed	-$248K	–	460
2022 Q1	$248K	Buy	748 +13	+2%	+$4K	0.05%	362
2021 Q4	$264K	Hold	735	–	–	0.05%	338
2021 Q3	$239K	Hold	735	–	–	0.04%	331
2021 Q2	$229K	Hold	735	–	–	0.04%	321
2021 Q1	$234K	Hold	735	–	–	0.05%	287
2020 Q4	$238K	Hold	735	–	–	0.05%	252
2020 Q3	$204K	Buy	+735	New	+$212K	0.05%	223
2019 Q2	–	Sell	-735	Closed	-$210K	–	179
2019 Q1	$210K	Hold	735	–	–	0.09%	132
2018 Q4	$239K	Hold	735	–	–	0.11%	108
2018 Q3	$331K	Hold	735	–	–	0.14%	96
2018 Q2	$301K	Hold	735	–	–	0.14%	98
2018 Q1	$214K	Buy	+735	New	+$186K	0.11%	113
2016 Q3	–	Sell	-2,205	Closed	-$241K	–	113
2016 Q2	$241K	Hold	2,205	–	–	0.15%	97
2016 Q1	$209K	Buy	+2,205	New	+$186K	0.13%	102
2015 Q2	–	Sell	-735	Closed	-$46K	–	390
2015 Q1	$46K	Hold	735	–	–	0.04%	187
2014 Q4	$28K	Buy	+735	New	+$23.2K	0.02%	247

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Intersect Capital's ABMD Position: Q2 2022 in Review

Intersect Capital sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 748 shares — an estimated $248K sold.

Intersect Capital first reported a position in ABMD in Q4 2014 and held it in 16 quarters. The position peaked at $331K in Q3 2018. 495 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

Intersect Capital reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
Intersect Capital sold 748 Abiomed Inc shares in Q2 2022, an estimated $248K.
Intersect Capital first reported a position in Abiomed Inc in Q4 2014 and held it in 16 quarters.
Intersect Capital's Abiomed Inc position peaked at $331K in Q3 2018.
495 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Intersect Capital's 13F filing for Q2 2022, filed 2 Sep 2022.